Victoria A. Muggia

Tuberculosis

Syphilis

Osteomyelitis

General/Other

OPAT

Recurrent UTI

https://einsteinmed.edu/faculty/10966/Marla-Keller

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

einstein-dept-obstetrics-gynecology-womens-health

Gender

Female

Phone

718-430-3240

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Professor

Division

Infectious Diseases

Type

Academic

Department

Department of Obstetrics & Gynecology and Women's Health

Department Link

Rank

Professor

Type

Clinical

Title

Professor, Department of Medicine (Infectious Diseases)

Type

Clinical

Title

Professor, Department of Obstetrics & Gynecology and Women's Health

Type

Clinical

Title

Executive Dean

Type

Clinical

Title

Jacob A. and Jeanne E. Barkey Chair in Medicine

Type

Administrative

Title

Executive Dean

Type

Administrative

Title

Jacob A. and Jeanne E. Barkey Chair in Medicine

Locations

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.88072 40.88002)

Address Line 1

111 East 210th Street

City

Bronx

State

Zip

10461-2401

Location Title

Montefiore Medical Center

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.84563 40.84596)

Address Line 1

1575 Blondell Avenue

City

Bronx

State

Zip

10461-2601

Location Title

Montefiore Medical Park at 1575 Blondell

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.8459022 40.8504961)

Building

Belfer Building

Room

311

Address Line 1

Albert Einstein College of Medicine

Address Line 2

Jack and Pearl Resnick Campus

Address Line 3

1300 Morris Park Avenue

City

Bronx

State

Zip

10461

Location Title

Albert Einstein College of Medicine

Education and Trainings

Education Type Label

Medical Education

Education Institution

New York University School of Medicine

Education Type Label

Fellowship

Education Institution

Beth Israel Deaconess Hosp - East Campus

Education Type Label

Residency

Education Institution

Beth Israel Deaconess Hosp - East Campus

Professional Interests

Marla Keller, MD is a tenured Professor of Medicine, Obstetrics & Gynecology and Women’s Health, named holder of the Jacob and Jeanne Barkey Chair in Medicine, and Executive Dean. She previously served as Interim Senior Associate Dean for Clinical and Translational Research, Director of the Harold and Muriel Block Institute for Clinical and Translational Research, and Vice Chair of Research for the Department of Medicine.
Dr. Keller received a Bachelor of Arts degree in psychology from Cornell University and a medical degree from New York University School of Medicine. She completed residency training in Internal Medicine at Beth Israel Hospital and fellowship in the combined Infectious Diseases training program at Beth Israel Hospital and Brigham & Women's Hospital in Boston, MA. She completed the Clinical Research Training Program at Mount Sinai School of Medicine and was on the faculty at Mount Sinai for 9 years before arriving at Einstein and Montefiore in 2007. 
She is a practicing Infectious Diseases physician with a clinical and research interest in the prevention and treatment of human immunodeficiency virus (HIV) and herpes simplex virus (HSV) infection in adult and adolescent women. Her NIH-funded research includes the design and conduct of human studies to translate laboratory and animal findings to the clinic with the goal of developing novel preventive strategies to reduce the global burden of HIV and HSV. Her interest is in advancing development of topical pre-exposure prophylaxis (PrEP) strategies to reduce the sexual transmisssion of HIV and HSV-2. She has completed first-in-human and Phase 1 safety, pharmacokinetic (PK) and pharmacodynamic (PD) trials of novel vaginal microbicide candidates and formulations (gels, tablets, and rings) for PrEP and contraception. She has also led clinical studies to examine effects of HIV, HSV and bacterial vaginosis on female genital tract immunity and the vaginal microbiome.  
Dr. Keller is a co-investigator of the Bronx Clinical Research Site of the NIH-funded Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS) Combined Cohort Study (CCS). Her work with MACS/WIHS-CCS focuses on improving cervical cancer screening practices in women living with HIV infection.
Dr. Keller led the COVID-19 Treatment Taskforce for the Department of Medicine to provide guidance on therapeutic management of patients with COVID-19. She was a co-investigator on COVID-19 therapeutic trials and studies to understand immune responses to SARS-CoV-2 infection in adult and pediatric patients. She served as a scientific member of the NIH COVID-19 Treatment Guidelines Panel from 2020-2024.   
Dr. Keller is a member and fellow of the Infectious Disease Society of America (IDSA), a member of the Infectious Diseases Society of New York (IDSNY), and a member of the HIV Medical Association (HIVMA). She served for 9 years as a scientific member of the U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents Living with HIV.

Research Areas

HIV and women, vaginal microbicides, pre-exposure prophylaxis (PrEP), HIV clinical trials, women's health, HIV and herpes prevention, immune responses to COVID-19 infection, COVID-19 clinical trials

Research Profile

Clinical Profile

https://montefioreeinstein.org/profiles/1558389395/marla-j-keller

CHAM Provider

Off

Professional Title

M.D.

Clinical Focus

Dr. Keller's clinical focus centers on treating HIV and COVID-19 and offering in-patient infectious disease consultation.

Research Focus

Prevention and treatment of HIV infection in women, advancing the development of vaginal drugs and new strategies to prevent HIV and other sexually transmitted infections, immune responses to SARS-CoV-2 infection and COVID-19 clinical trials.

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/bbcb0ab4-8abf-4a3a-a499-eb171f4e7…

Selected Publications

Keller MJ, Mesquita PMM, Torres M, Cho S, Shust G, Madan RP, Cohen HW, Petrie J, Ford T, Soto-Torres L, Profy AT, Herold BC.  Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. PLoS One 5:e8781, 2010.
Keller MJ, Madan RP, Torres NM, Fazzari MJ, Cho S, Kalyoussef S, Shust G, Mesquita PMM, Louissaint N, Chen J, Cohen HW, Diament EC, Lee AC, Soto-Torres L, Hendrix CH, Herold BC. A randomized trial to assess anti-HIV activity in female genital tract secretions & soluble mucosal immunity following application of 1% tenofovir gel. PLoS One, 6:e16475, 2011.
Herold BC, Mesquita PMM, Madan Rp, Keller MJ. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections. American Journal of Reproductive Immunology, 65:325-333, 2011.
Keller MJ, Malone AM, Carpenter CA, Lo Y, Huang M, Corey L, Willis R, Nguyen C, Kennedy S, Gunawardana M, Guerrero D, Moss JA, Baum MM, Smith TJ, Herold BC. Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring. Journal of Antimicrobial Chemotherapy, 67:2005-12, 2012.
Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, Xue X, D'Souza G, Watts DH, Levine AM, Castle PE, Colie C, Palefsky JM, Strickler HD. Risk of cervical precancer and cancer among HIV-infected women with normal cytology and no evidence of oncogenic HPV infection.  JAMA, 308:362-369, 2012. 
Keller MJ, Madan RP, Shust G, Torres NM, Cho S, Khine H, Huang M, Corey L, Kim M, Herold BC. Changes in the soluble mucosal immune environment during genital herpes outbreaks.  Journal of Acquired Immune Deficiency Syndromes, 61:194-202, 2012.
Keller MJ, Carpenter CA, Lo Y, Einstein MH, Lu C, Fredricks DN, Herold BC. Phase I randomized safety study of twice daily dosing of Acidform vaginal gel: candidate antimicrobial contraceptive. PLoS One, 7:e46901, 2012.
Keller MJ, Buckley N, Katzen LL, Walsh J, Friedland B, Littlefield S, Lin J, Xue X, Cornelison T, Herold BC, Einstein MH. Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex. Sexually Transmitted Diseases, 40:939-943, 2013 
Herold BC, Keller MJ, Shi Q, Hoover DR, Carpenter CA, Parikh UM, Agnew KJ, Minkoff H, Colie C, Nowicki MJ, D’Souza G, Anastos K. Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 63:485-493, 2013.
Ursell LK, Gunawardana M, Chang S, Mullen M, Moss JA, Herold BC, Keller MJ, McDonald D, Gonzalez A, Knight R, Baum MM. Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings. Antiviral Research, 102:87-94, 2014.
Dominguez-Villar M, Gautron A, de Marcken M, Keller MJ, Hafler DA. TLR7 induces anergy in human CD4(+) T cells. Nature Immunology, 16:118-128, 2015. 
Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Castle PE, Anastos A, Xie X, Minkoff H, Xue X, D’Souza G, Flowers L, Levine AM, Colie C, Rahangdale L, Fischl MA, Palefsky JM, Strickler HD. Cervical precancer risk in HIV-infected women who test positive for oncogenic human papillomavirus despite a normal Pap test. Clin Infect Dis, 61:1573-1581, 2015. 
Nakra NA, Madan RP, Buckley N, Huber AM, Freiemuth J, Espinoza L, Walsh J, Parikh UM, Penrose KJ, Keller MJ, Herold BC. Loss of innate host defense following unprotected vaginal sex. Journal of Infectious Diseases, 213:840-847, 2016. 
Keller MJ, Mesquita PM, Marzinke MA, Teller R, Espinoza L, Atrio JM, Lo Y, Frank B, Srinivasan S, Fredricks DN, Rabe L, Anderson PL, Hendrix CW, Kiser PF, Herold BC.  A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring. AIDS, 30:743-751, 2016. 
Keller MJ, McGinn AP, Lo Y, Huber A, Espinoza L, Minkoff H, Colie C, Nowicki MJ, D’Souza G, Anastos K. Longitudinal assessment of systemic and genital tract inflammatory markers and endogenous genital tract E. coli inhibitory activity in HIV-infected and uninfected women.  American Journal of Reproductive Immunology, 75:631-42, 2016.
Novetsky AP, Keller MJ, Gradissimo A, Chen Z, Morgan SL, Xue X, Strickler HD, Fernandez-Romero JA, Burk R, Einstein MH. In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel. Gynecologic Oncology, 143:313-18, 2016.
Massad LS, Keller MJ, Xie X, Minkoff H, Palefsky J, D’Souza G, Colie C, Villacres MC, Strickler HD. Multitype infections with human papillomavirus: impact of HIV coinfection. Sexually Transmitted Diseases, 43:637-641, 2016.
Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkoff H, Keller MJ, Fischl M, Burk RD, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, D’Souza G.  Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS, 31:1035-1044, 2017.
Mesquita PM, Preston-Hurlburt P, Keller MJ, Vudattu N, Espinoza L, Altrich M, Anastos K, Herold KC, Herold BC. Role of IL-32 in HIV reactivation and its link to HIV-HSV coinfection. Journal of Infectious Diseases, 215:614-622, 2017.
Watnick D, Keller MJ, Stein K, Bauman LJ. Acceptability of a tenofovir disoproxil fumarate vaginal ring for HIV prevention among women in New York City. AIDS and Behavior, 22:421-436, 2018.
Taneva E, Sinclair S, Mesquita PMM, Weinrick B, Cameron SA, Cheshenko N, Reagle K, Frank B, Keller MJ, Srinivasan S, Fredricks D, Herold BC. Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight 3(13):e99545, 2018.
Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Anastos K, Xie X, Minkoff H, Xue X, Reimers LL, Kuniholm M, D’Souza G, Colie C, Palefsky JM, Strickler HD. Racial differences in HPV types among US women with HIV and cervical precancer. AIDS, 32:2821-2826, 2018.
Murphy K, Keller MJ, Anastos K, Sinclair S, Devlin JC, Shi Q, Hoover DR, Starkman B, McGillick J, Mullis C, Minkoff H, Dominguez-Bello MG, Herold BC. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection. PLoS One, 14:e0216049, 2019.
Keller MJ, Huber A, Espinoza L, Serrano MG, Parikh HI, Buck GA, Gold JA, Wu Y, Wang T, Herold BC. Impact of herpes simplex virus type 2 and human immunodeficiency virus dual infection on female genital tract mucosal immunity and the vaginal microbiome. Journal of Infectious Diseases, 220:852-861, 2019.
Keller MJ, Wood L, Billingsley JM, Ray LL, Goymer J, Sinclair S, McGinn AP, Marzinke M, Frank B, Srinivasan S, Liu C, Atrio JM, Espinoza L, Mugo NR, Spiegel HML, Anderson PL, Fredricks DN, Hendrix CW, Marrazzo J, Bosinger SE, Herold BC. Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomized, controlled trial. Lancet HIV, 6:e498-e508, 2019.
Keller MJ, Kitsis EA, Arora S, Chen JT, Agarwal S, Ross MJ, Tomer Y, Southern W. Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19.  Journal of Hospital Medicine, 15:489-493, 2020.
Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, Orner E, Sy S, Chandran K, Dziura J, Almo SC, Ring A, Keller MJ, Herold KC, Herold BC. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Science Translational Medicine, 12(564): eabd5487, 2020.
Strickler HD, Keller MJ, Hessol NA, Eltoum IE, Einstein MH, Castle PE, Massad LS, Flowers L, Rahangdale L, Atrio JM, Ramirez C, Minkoff H, Adimora AA, Ofotokun I, Colie C, Huchko MJ, Fischl M, Wright R, D’Souza G, Leider J, Diaz O, Sanchez-Keeland L, Shrestha S, Xie X, Xue X, Anastos K, Palefsky JM, Burk RD. Primary HPV and molecular cervical cancer screening in US women living with HIV. Clinical Infectious Diseases, 72:1529-1537, 2021.
Pau AK, Aberg J, Baker J, Belperio PS, Coopersmith C, Crew P, Glidden DV, Grund B, Gulick RM, Harrison C, Kim A, Lane HC, Masur H, Sheikh V, Singh K, Yazdany J, Tebas P.  Convalescent plasma for the treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Annals of Internal Medicine, 174(1):93-95, 2021.
Tomer Y, Gong MN, Keller MJ, Southern W, Kitsis EA, Kajita GR, Shapiro LI, Jariwala S, Epstein EJ. Teamwork and leadership under fire at the epicenter of the COVID-19 epidemic in the Bronx. Frontiers in Medicine, 8:610100, 2021.
Pierce CA, Sy S, Galen B, Goldstein DY, Orner E, Keller MJ, Herold KC, Herold BC. Natural mucosal barriers and COVID-19 in children. JCI Insight, 6(9):e148694, 2021.
Serebrenik JS, Wang T, Hunte R, Srinivasan S, McWalters J, Tharp GK, Bosinger SE, Fiedler TL, Atrio JM, Murphy K, Barnett R, Ray LR, Krows ML, Fredricks DN, Irungu E, Ngure K, Mugo N, Marrazzo J, Keller MJ, Herold BC. Differences in vaginal microbiota, host transcriptome and proteins in women with bacterial vaginosis are associated with metronidazole response.  Journal of Infectious Diseases 224(12):2094-2104, 2021.
Kim M, Marantz P, Suadicani S, Milman S, Keller MJ. Challenges in catalyzing and sustaining research in translational science. Journal of Clinical and Translational Science 7;e217, 1-5, 2023.
Murphy K, Gromisch M, Srinivasan S, Wang T, Wood L, Proll S, Liu C, Fiedler T, Valint DJ, Fredricks DN, Keller MJ, Herold BC. IgA coating of vaginal bacteria is reduced in the setting of bacterial vaginosis (BV) and preferentially targets BV-associated bacteria. Infection and Immunity 92(1):e0037323, 2024.

EMR ID

4956

Biography

Marla Keller, MD is a tenured Professor of Medicine, Obstetrics & Gynecology and Women’s Health, named holder of the Jacob and Jeanne Barkey Chair in Medicine, and Executive Dean. She previously served as Interim Senior Associate Dean for Clinical and Translational Research, Director of the Harold and Muriel Block Institute for Clinical and Translational Research, and Vice Chair of Research for the Department of Medicine. Her clinical focus centers on treating HIV and COVID-19 and offering in-patient infectious disease consultation.After earning her Doctor of Medicine at New York University in 1993, Dr. Keller completed her internship and residency in internal medicine at Beth Israel Hospital in 1996. She completed a fellowship in infectious disease in 1998 from the combined training program at Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital. Dr. Keller went on to participate in a Clinical Research Training Program at Mount Sinai School of Medicine, which she completed in 2002. In 2018, Dr. Keller earned a Certification in Leadership Development for Physicians in Academic Health Centers from Harvard University.Building on her clinical focus, Dr. Keller’s research interests include the prevention and treatment of HIV infection in women, advancing the development of vaginal drugs and new strategies to prevent HIV and other sexually transmitted infections, immune responses to SARS-CoV-2 infection and COVID-19 clinical trials. She has been Principal Investigator or Co-Investigator on many NIH-funded research projects and clinical trials, and she has given national and international presentations. Her work has been published in numerous peer-reviewed journals.Dr. Keller is board certified in Infectious Diseases by the American Board of Internal Medicine. She is a member of several professional organizations, including the Infectious Disease Society of America, the HIV Medicine Association and the Infectious Disease Society of New York. Dr. Keller has won several awards for her work, including the Infectious Disease Mentoring Award from Montefiore in 2013, the COVID-19 Distinguished Service Award from the Department of Medicine in 2021 and the Spirit of Achievement Changemaker Award from Einstein in 2023. She was also named a New York Super Doctor from 2011 to 2015.

Is Open Scheduling

Off

Robert M. Grossberg

Read more about Robert M. Grossberg

Robert M. Grossberg

https://assets.montefioreeinstein.org/profiles/images/physphoto/Grossberg_Robert_M_MD_11114676.jpg

Provider

Faculty

First Name

Robert

Last Name

Grossberg

NPI

1538259338

Faculty ID

9799

CMO Specialties

Clinical Terms

Travel Shots

Oncology Related

LVAD

https://einsteinmed.edu/faculty/9799/Robert-Grossberg

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

Gender

Male

Provider Type

Primary Care

rgrossbe@montefiore.org

Phone

718-920-5276

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Professor

Division

Infectious Diseases

Locations

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.88133 40.88109)

Address Line 1

3444 Kossuth Avenue

City

Bronx

State

Zip

10467-2241

Location Title

Montefiore Medical Group-Family Care Center (FCC)

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.87862 40.88032)

Address Line 1

3400 Bainbridge Avenue

City

Bronx

State

Zip

10467-240

Location Title

Montefiore Greene Medical Arts Pavilion

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.88072 40.88002)

Address Line 1

111 East 210th Street

City

Bronx

State

Zip

10461-2401

Location Title

Montefiore Medical Center

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.84563 40.84596)

Address Line 1

1575 Blondell Avenue

City

Bronx

State

Zip

10461-2601

Location Title

Montefiore Medical Park at 1575 Blondell

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.8798833 40.8799447)

Room

NWG-46

Address Line 1

Montefiore Medical Center

Address Line 3

111 East 210th Street

City

Bronx

State

Zip

10467

Location Title

Montefiore Medical Center

Education and Trainings

Education Type Label

Medical Education

Education Institution

The Warren Alpert Medical School of Brown University

Education Type Label

Fellowship

Education Institution

Hospital of the University of Pennsylvania

Education Type Label

Residency

Education Institution

Hospital of the University of Pennsylvania

Professional Interests

Clinical studies of HIV infection, adherence, and tuberculosis

Research Profile

Clinical Profile

https://montefioreeinstein.org/profiles/1538259338/robert-m-grossberg

CHAM Provider

Off

Professional Title

M.D.

Clinical Focus

Management of HIV infection

Research Focus

New antiretroviral medication and new strategies to treat HIV.

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/f627e8d6-6e39-434e-a1ee-f150126fb…

EMR ID

4603

Biography

Robert Grossberg, MD, is Medical Director, Center for Positive Living/Infectious Diseases Clinic and Professor, Medicine at Montefiore-Einstein. His clinical focus is on the management of HIV infection. He has over 20 years of experience in treating patients with HIV. Dr. Grossberg also sees patients with general infectious disease conditions.After obtaining his undergraduate degree at Brown University in 1992, Dr. Grossberg earned his Doctor of Medicine at Brown University School of Medicine in 1996. He completed an internal medicine internship and residency at the Hospital of the University of Pennsylvania in 1999. Dr. Grossberg remained at this institution to complete an infectious diseases fellowship in 2001.Dr. Grossberg has extensive experience in clinical trials, particularly trials of new antiretroviral medication and new strategies to treat HIV. He has been the principal investigator (PI) of numerous industry-sponsored studies and collaborated with investigators throughout the country and internationally. Dr. Grossberg was also the PI at Montefiore for several pivotal studies investigating treatments for COVID-19. His work has been published in numerous peer-reviewed journals, books, chapters, articles and abstracts, and he has given invited presentations nationally. Dr. Grossberg has been a reviewer for scientific journals including AIDS and Behavior, Clinical Infectious Diseases and the European Journal of Clinical Microbiology and Infectious Diseases.Dr. Grossberg is board certified in Internal Medicine and Infectious Diseases. He is a member of the Infectious Diseases Society of America, the HIV Medicine Association and the Infectious Diseases Society of New York. Dr. Grossberg has been named in Castle Connolly’s “Top Doctors: New York Metro Area” for several years and in New York Magazine’s Top Doctors in 2021.

Is Open Scheduling

Off

Uriel R. Felsen

Read more about Uriel R. Felsen

Uriel R. Felsen

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/3e899ba0-0770-11ec-8c2b-df825007d876.jpg

Provider

Faculty

First Name

Uriel

Last Name

Felsen

NPI

1063709665

Faculty ID

13932

CMO Specialties

Clinical Terms

Spontaneous Bacterial Peritonitis

Chronic Cough

Heart Valve Disease

Liver Function Tests

Gastrointestinal Bleeding

Reactive Airway Disease

Bacterial Endocarditis

Embolism And Thrombosis

Heart Failure

Sinusitis

Warfarin

Hospital-Associated Pneumonia

Head And Neck Cancer

Altered Mental Status

Acute Kidney Injury

Respiratory Failure

Acute Respiratory Distress Syndrome

Osteomyelitis

Right-Sided Heart Failure

Kidney Transplant

Multiple Trauma

Clostridium Difficile Colitis

Peritoneal Dialysis

Hypertensive Emergency

Upper Gastrointestinal Bleeding

Chronic Kidney Disease

Unconsciousness

Intracranial Hemorrhage

Deep Vein Thrombosis (DVT)

Middle East Respiratory Syndrome

Peripheral Artery Disease

Shoulder Pain

Thoracic Aortic Aneurysm

Aortic Dissection

Abdominal Pain

Pelvic Inflammatory Disease

E. Coli Infection

Colorectal Cancer Screening

Flank Pain

Pain

HIV Disease

HIV Infection

Recurrent UTI

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

Gender

Male

ufelsen@montefiore.org

Phone

718-920-8588

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Associate Professor

Johanna P. Daily

Read more about Johanna P. Daily

Johanna P. Daily

https://assets.montefioreeinstein.org/profiles/images/physphoto/Daily_Johanna_MD_420x504.jpg

Provider

Faculty

First Name

Johanna

Last Name

Daily

NPI

1679523187

Faculty ID

11598

CMO Specialties

Infectious Disease

Clinical Terms

OPAT

Travel Vaccinations

Hepatitis C

Lyme Disease

MRSA Infection

Syphilis

Tuberculosis

https://einsteinmed.edu/faculty/11598/Johanna-Daily

Hepatitis B

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

einstein-dept-microbiology-immunology

Gender

Female

jdaily@montefiore.org

Phone

718-678-1176

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Professor

Division

Infectious Diseases

Type

Academic

Department

Department of Microbiology & Immunology

Department Link

Rank

Professor

Type

Administrative

Locations

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.845 40.85026)

Address Line 1

1825 Eastchester Road

City

Bronx

State

Zip

10467-2404

Location Title

Montefiore Weiler Hospital

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.84563 40.84596)

Address Line 1

1575 Blondell Avenue

City

Bronx

State

Zip

10461-2601

Location Title

Montefiore Medical Park at 1575 Blondell

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.845838 40.8516937)

Room

502

Address Line 1

Albert Einstein College of Medicine

Address Line 2

Michael F. Price Center

Address Line 3

1301 Morris Park Avenue

City

Bronx

State

Zip

10461

Location Title

Albert Einstein College of Medicine

Education and Trainings

Education Type Label

Medical Education

Education Institution

SUNY at Syracuse College of Medicine

Education Type Label

Fellowship

Education Institution

Beth Israel Deaconess Hosp

Education Type Label

Residency

Education Institution

Tufts New England Medical Center

Professional Interests

Our primary research interest is in the biology, pathogenesis and immunology of Plasmodium falciparum. Patients infected with this parasite can be completely asymptomatic or develop severe disease resulting in death. The goal of our research has been to define the molecular mechanisms that underlie this variation in disease outcomes in P. falciparum. Toward this goal, we have developed a new pathogenesis model through the analysis of in vivo parasite biology and associated host factors using a whole genome and metabolomic approach. We have identified novel parasite biology when it resides in the human host and idnetified a putative mediator of coma in cerebral malaria.  We also are studying adjunctive therapy to improve outcomes in severe malaria using the animal model.   We carry out field based translational studies in cohorts infected with malaria in Africa and test hypothesis in the animal model of malaria.  The long term goal is to identify parasite and host processes involved in disease to serve as targets for vaccine or chemotherapeutic development.
Our group also conducts studies to characterize the effect of COVID-19 on brain function in collaboration with Dr. Michael Liptons group and identifying patients with other emerging viral infections in collaboration with Drs Chandran and Lai's group.

Research Profile

Clinical Profile

https://montefioreeinstein.org/profiles/1679523187/johanna-p-daily

CHAM Provider

Off

Professional Title

M.D.

M.S.

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/8651d9ce-3cac-41e8-81e7-8e6a8b98f…

Selected Publications

Keswani T, Obeidallah A, Nieves E, Sidoli S, Fazzari M, Taylor T, Seydel K, Daily JP. Pipecolic Acid, a Putative Mediator of the Encephalopathy of Cerebral Malaria and the Experimental Model of Cerebral Malaria. J Infect Dis. 2022 Feb 15;225(4):705-714. doi: 10.1093/infdis/jiab615. PMID: 34932816; PMCID: PMC8844588.
Mita-Mendoza NK, Magallon-Tejada A, Parmar P, Furtado R, Aldrich M, Saidi A, Taylor T, Smith J, Seydel K, Daily JP. Dimethyl fumarate reduces TNF and Plasmodium falciparum induced brain endothelium activation in vitro. Malar J. 2020 Oct 21;19(1):376. doi: 10.1186/s12936-020-03447-7. PMID: 33087130; PMCID: PMC7579885.
Chen V, Daily JP. Tafenoquine: the new kid on the block. Curr Opin Infect Dis. 2019 Oct;32(5):407-412. doi: 10.1097/QCO.0000000000000574. PMID: 31305490.
Lasso G, Khan S, Allen SA, Mariano M, Florez C, Orner EP, Quiroz JA, Quevedo G, Massimi A, Hegde A, Wirchnianski AS, Bortz RH 3rd, Malonis RJ, Georgiev GI, Tong K, Herrera NG, Morano NC, Garforth SJ, Malaviya A, Khokhar A, Laudermilch E, Dieterle ME, Fels JM, Haslwanter D, Jangra RK, Barnhill J, Almo SC, Chandran K, Lai JR, Kelly L, Daily JP, Vergnolle O. Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes. PLoS Comput Biol. 2022 Jan 18;18(1):e1009778. doi: 10.1371/journal.pcbi.1009778. PMID: 35041647; PMCID: PMC8812869.
Ortigoza MB, Yoon H, Goldfeld KS, Troxel AB, Daily JP, Wu Y, Li Y, Wu D, Cobb GF, Baptiste G, O'Keeffe M, Corpuz MO, Ostrosky-Zeichner L, Amin A, Zacharioudakis IM, Jayaweera DT, Wu Y, Philley JV, Devine MS, Desruisseaux MS, Santin AD, Anjan S, Mathew R, Patel B, Nigo M, Upadhyay R, Kupferman T, Dentino AN, Nanchal R, Merlo CA, Hager DN, Chandran K, Lai JR, Rivera J, Bikash CR, Lasso G, Hilbert TP, Paroder M, Asencio AA, Liu M, Petkova E, Bragat A, Shaker R, McPherson DD, Sacco RL, Keller MJ, Grudzen CR, Hochman JS, Pirofski LA; CONTAIN COVID-19 Consortium for the CONTAIN COVID-19 Study Group, Parameswaran L, Corcoran AT, Rohatgi A, Wronska MW, Wu X, Srinivasan R, Deng FM, Filardo TD, Pendse J, Blaser SB, Whyte O, Gallagher JM, Thomas OE, Ramos D, Sturm-Reganato CL, Fong CC, Daus IM, Payoen AG, Chiofolo JT, Friedman MT, Wu DW, Jacobson JL, Schneider JG, Sarwar UN, Wang HE, Huebinger RM, Dronavalli G, Bai Y, Grimes CZ, Eldin KW, Umana VE, Martin JG, Heath TR, Bello FO, Ransford DL, Laurent-Rolle M, Shenoi SV, Akide-Ndunge OB, Thapa B, Peterson JL, Knauf K, Patel SU, Cheney LL, Tormey CA, Hendrickson JE. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial. JAMA Intern Med. 2022 Feb 1;182(2):115-126. doi: 10.1001/jamainternmed.2021.6850. PMID: 34901997; PMCID: PMC8669605.
Ahmed A, Daily JP, Lescano AG, Golightly LM, Fasina A. Challenges and Strategies for Biomedical Researchers Returning to Low- and Middle-Income Countries after Training. Am J Trop Med Hyg. 2020 Mar;102(3):494-496. doi: 10.4269/ajtmh.19-0674. PMID: 31912776; PMCID: PMC7056415.

EMR ID

5286

Is Open Scheduling

Off

James C.M. Brust

Read more about James C.M. Brust

James C.M. Brust

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/d035eaf0-5e6f-11ef-870a-2d4e33c2095c.jpg

Provider

Faculty

First Name

James

Last Name

Brust

NPI

1508998485

Faculty ID

11307

CMO Specialties

Internal Medicine

Infectious Disease

Clinical Terms

Hepatic Encephalopathy

Candidiasis

Acute Tubular Necrosis

Mastoiditis

Seasonal Affective Disorder

Hospital-Associated Pneumonia

Necrotizing Fasciitis

Schatzki's Ring

Bowel Obstruction

Primary Biliary Cholangitis

Abnormal Uterine Bleeding

Rheumatoid Arthritis

Diverticulitis

Pneumonia

Coronary Artery Disease

Abdominal Pain

Insulin

Acute Respiratory Distress Syndrome

Hypertensive Emergency

Uvulitis

Chronic Pain Syndrome

Reactive Airway Disease

Acute Urinary Retention

Paroxysmal Atrial Fibrillation

Polymyalgia Rheumatica

Diabetic Peripheral Neuropathy

Substance Use Disorder

Clostridium Difficile Colitis

Tuberculosis Screening

Diabetic Neuropathy

Multi-Infarct Dementia

Diverticular Disease

Lower Gastrointestinal Bleeding

Altered Mental Status

Chronic Kidney Disease

Recreational Drug Use

Lung Infection

Lower Respiratory Tract Infection

HIV Disease

HIV Infection

LGBT Care

https://einsteinmed.edu/faculty/11307/James-Brust

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

Languages

Spanish

Gender

Male

james.brust@einsteinmed.edu

Phone

718-920-6482

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Professor

Division

General Internal Medicine

Locations

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.88133 40.88109)

Address Line 1

3444 Kossuth Avenue

City

Bronx

State

Zip

10467-2241

Location Title

Montefiore Medical Group-Family Care Center (FCC)

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.84563 40.84596)

Address Line 1

1575 Blondell Avenue

City

Bronx

State

Zip

10461-2601

Location Title

Montefiore Medical Park at 1575 Blondell

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.881779 40.87926)

Address Line 1

Montefiore Medical Center

Address Line 3

3300 Kossuth Avenue

City

Bronx

State

Zip

10467

Location Title

Montefiore Medical Center

Education and Trainings

Education Type Label

Medical Education

Education Institution

Columbia University College of Physicians/Surgeons

Education Type Label

Fellowship

Education Institution

Columbia Univ College of Phys & Surgeons

Education Type Label

Residency

Education Institution

New York Presbyterian Hospital

Professional Interests

Dr. Brust is a Professor of Medicine, with joint appointments in the Divisions of General Internal Medicine and Infectious Diseases. He graduated from the College of Physicians & Surgeons at Columbia University and completed both a residency in Internal Medicine and a fellowship in Infectious Diseases at the Columbia University Medical Center. 
Dr. Brust's research is focused on the dual epidemics of multidrug-resistant tuberculosis (MDR TB) and HIV in South Africa. With multiple US and international collaborators, his multidisciplinary research group is studying treatment outcomes of MDR TB/HIV co-infected patients, transmission patterns of drug-resistant TB, pharmacology of new and repurposed TB medications, and genetic mechanisms of drug-resistance. He has funding from NIAID to examinine the emergence of resistance to the new TB medication bedaquiline in patients with MDR and XDR TB.

Research Areas

Epidemiology and treatment outcomes of drug-resistant tuberculosis and HIV in South Africa. A particular focus is on novel therapeutics and emergence of resistance as drugs are introduced into the South African TB program.

Research Profile

Clinical Profile

https://montefioreeinstein.org/profiles/1508998485/james-cm-brust

CHAM Provider

Off

Professional Title

M.D.

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/57be43a3-1a8c-4da6-8762-881ca6b78…

Selected Publications

Selected Publications
 
Brust JCM, Gandhi NR, Carrara H, Osburn G and Padayatchi N. High Treatment Failure and Default Rates for Patients with MDR TB in KwaZulu-Natal, South Africa, 2000-2003. Int J Tuberc Lung Dis. 2010;14(4):413-9
 
Brust JCM, Shah NS, Scott M, Chaiyachati K, Lygizos M, van der Merwe TL, Bamber S, Radebe Z, Loveday M, Moll AP, Margot B, Lalloo UG, Friedland GH, Gandhi NR. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis 2012; 16:998-1004.
 
Brust JCM, Shah NS, van der Merwe TL, Bamber S, Ning Y, Heo M, Moll AP, Loveday M, Lalloo UG, Friedland GH, Gandhi NR. Adverse events in an integrated, home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 2013; 62:436-440.
 
Brust JCM, Berman AR, Zalta B, Haramati LB, Ning Y, Heo H, van der Merwe TL, Bamber S, Moll AP, Friedland GH, Shah NS, Gandhi NR.Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.PLoS One 2013; 8(9): e73975. doi:10.1371/journal.pone.0073975
 
Gandhi NR, Brust JCM, Moodley P, Weissman D, Heo M, Ning Y, Moll AP, Friedland GH, Sturm W, Shah NS. Low M. tuberculosis strain diversity among multidrug- and extensively drug-resistant tuberculosis isolates from Tugela Ferry, South Africa, 2005-2006. Emerg Infect Dis 2014; 20(3):394-401.
 
Loveday M, Wallengren K, Brust J, Roberts J, Voce A, Margot B, Ngozo J, Master I, Cassell G, Padayatchi N. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2015 Feb;19(2):163-71.
 
Niehaus AJ, Gandhi NR, Mathema B, Mlisana K, Brust JCM. High prevalence of inhA promoter mutations among patients with drug-resistant tuberculosis in KwaZulu-Natal, South Africa. PLoS One 2015; 10(9):e0135003. doi: 10.1371/journal.pone.0135003
 
Shah NS, Auld S, Brust JCM, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T, Morris N, Mpangase P, Vally Omar S, Brown T, Narenchania A, Shaskina E, Kapwata T, Kreiswirth B, Gandhi NR. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa. N Engl J Med 2017; 376(3):243-253
 
Brust JCM, Shah NS, Mlisana K, Moodley P, Allana S, Campbell A, Johnson BA, Master I, Mthiyane T, Lachman S, Larkan L-M, Ning Y, Malik A, Smith JP, Gandhi NR. Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa. Clin Infect Dis. 2018; 66(8):1246-1253.
 
Wasserman S, Denti P, Brust JCM, Abdelwahab M, Hlungulu S, Wiesner L, Norman J, Sirgel FA, Warren RM, Esmail A, Dheda K, Gandhi NR, Meintjes G, Maartens G. Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection. Antimicrob Agents Chemother 2019 63(3):e02164-18
 
Meintjes G, Brust JCM, Nutall J, Maartens G. Management of active tuberculosis in adults with HIV. Lancet HIV 2019; 6: e463–74
 
Smith JP, Gandhi NR, Shah NS, Mlisana K, Moodley P, Johnson BA, Allana S, Campbell A, Nelson KN, Master I, Brust JCM. The impact of concurrent antiretroviral therapy and MDR-TB treatment on adverse events. J Acquir Immune Defic Syndr 2020; 83(1):47-55
 
Ngwalero P*, Brust JCM*, van Beek SW, Wasserman S, Maartens G, Meintjes G, Joubert A, Norman J, Castel S, Gandhi NR, Denti P, McIlleron H, Svensson EM, Wiesner L. Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB. Antmicrob Agents Chemother. 2021; 65(11):e0239920. doi: 10.1128/AAC.02399-20
 
Brust JCM, Gandhi NR, Wasserman S, Maartens G, Omar SV, Ismail NA, Campbell A, Joseph L, Hahn A, Allana S, Hernandez-Romieu AC, Zhang C, Mlisana K, Viljoen CA, Zalta B, Ebrahim I, Franczek M, Master I, Ramangoaela L, Te Riele J, Meintjes G; PROBeX Study Team. Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study. Clin Infect Dis. 2021; 73(11):2083-2092

EMR ID

5132

Is Open Scheduling

Off

Peter L. Alpert

Read more about Peter L. Alpert

Peter L. Alpert

https://assets.montefioreeinstein.org/profiles/images/physphoto/Alpert_Peter_MD_420x504.jpg

Provider

Faculty

First Name

Peter

Last Name

Alpert

NPI

1104916907

Faculty ID

1967

CMO Specialties

Clinical Terms

Travel Shots

OPAT

Septicemia

LGBT Care

https://einsteinmed.edu/faculty/1967/Peter-Alpert

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

Languages

Spanish

Gender

Male

palpert@montefiore.org

Phone

718-920-7364

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Assistant Professor

Division

Infectious Diseases

Locations

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.87862 40.88032)

Address Line 1

3400 Bainbridge Avenue

City

Bronx

State

Zip

10467-240

Location Title

Montefiore Greene Medical Arts Pavilion

Is Primary

Off

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.84563 40.84596)

Address Line 1

1575 Blondell Avenue

City

Bronx

State

Zip

10461-2601

Location Title

Montefiore Medical Park at 1575 Blondell

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.8799255 40.8798864)

Building

Schiff Pavilion

Room

S2-2

Address Line 1

Montefiore Medical Center

Address Line 2

AIDS Center

Address Line 3

111 East 210th Street

City

Bronx

State

Zip

10467

Location Title

Montefiore Medical Center

Education and Trainings

Education Type Label

Medical Education

Education Institution

New York Medical College

Education Type Label

Fellowship

Education Institution

Montefiore Medical Center

Education Type Label

Residency

Education Institution

Montefiore Medical Center

Professional Interests

Clinical HIV studies

Research Profile

Clinical Profile

https://montefioreeinstein.org/profiles/1104916907/peter-l-alpert

CHAM Provider

Off

Professional Title

M.D.

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/99e17510-95ac-4d43-99e3-ce15f3dd9…

EMR ID

3858

Is Open Scheduling

Off

Jacqueline M. Achkar

Read more about Jacqueline M. Achkar

Jacqueline M. Achkar

https://assets.montefioreeinstein.org/profiles/images/physphoto/Achkar_Jacqueline_MD_420x504_2019.jpg

Provider

Faculty

First Name

Jacqueline

Last Name

Achkar

NPI

1750488573

Faculty ID

10390

CMO Specialties

Clinical Terms

C diff infection

Bone infection

Abscess

Travel Vaccinations

LVAD

MRSA Infection

Syphilis

Tuberculosis

MAI Infection

Recurrent UTI